WHO ICTRP trial
Quality of life and influencing factors of hematological malignancies treated…
ChiCTR2200058072 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200058072 |
|---|---|
| Public title | Quality of life and influencing factors of hematological malignancies treated with chimeric antigen receptor-T cell |
| Scientific title | Quality of life and influencing factors of hematological malignancies treated with chimeric antigen receptor-T cell |
| Primary sponsor | The First Affiliated Hospital, Zhejiang University of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | hematological malignancies |
| Interventions | case series:None |
| Registration date | Mar 28, 2022 |
| Target size | case series:80 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: